搜索
26 1320107GansuScienceandTechnologyVol.26 No.13Jul. 2010UASB吕建国1,2,张明霞1(1.,730020;2.,730020) :UASB,。UASB,UASB。:UASB;;:X703 (UASB),WageningenLettinga2070[1],,、,,,。UASBCOD20kg/(m·d),4h,,,,,COD90%,[2～4]。1 UASB1.1 UASB[5],UASB。(7～30℃),COD、、(VFA)。:16.2～25℃,pH6.6～8.2,UASB。,COD65%,UASB。[6]UASB,UASB3h、,,COD《》(GB8978—1996),SS。[7]UASB(15～23℃),UASB,35d,,,。[8]UASB,,5.33h,COD57.21%,BOD69.32%,0.087m3/(m3·d),UASB。[9]UASB—,UASB。,,UASB6h,CODBOD50%60%,TP15%～38%。HRT5.67h10h,VFA,pH6.5～7.5,CODBOD59%19%,CODBOD25%24%。[10]UASB,6:20℃,6.4h、5.0h,UASB,。,SS,283mg/L,UASBSS84%。SS48%SCOD,SCOD:TCOD0.300.71,。1.2 UASB[11]UASB,、、,23.9gVSS/L,COD4000～5000mg/L,10kgCOD/(m3·d),34～36℃,30d。,COD4500mg/L7500mg/L,2.24kgCOD/(m3·d)4.03kgCOD/(m3·d),40d,COD94.8%。,COD6700～8300mg/L,3.67kgCOD/(m3·d),COD290～430mg/L,COD94.9%。,,,。[12]UASB,COD10kg/(m3·d),COD90%。,。[13]UASB,。COD5000～6000mg/L,HRT24h,4.5～6.2kg/(m3·d),70%～80%,。2 UASB2.1 UASB+SBR[14]UASB+SBR,,UASB+SBR,SO-42,(21d)。UASB,COD34000mg/L,COD95%,COD1300mg/L。SBR,《》。[15]UASB+SBR,:UASB1.0m/h,COD4880mg/L,108%,UASBCOD408～626mg/L,COD88.1%～91.4%,90%。[16]UASB/SBR。,UASB/SBR,,,。,,《》(GB8978-1996),,。[17]UASB—SBR。,。,,,,。UASB,COD500mg/L,SBR,COD100mg/L。[18]UASB—SBR。:UASB—SBR,COD85%,BOD90%,SS85%,。、、。2.2 UASB+CASS,UASB+CASS。:COD1500～3000mg/L50mg/L、BOD1000～1500mg/L15mg/L,SS300～40050mg/L。、、[19]。、,COD20000mg/L,,UASB—CASS。,《》(GB8978—1996)[20]。UASB—CASS—[21]。,、,,,。[22]UASB,,,30d,,37d,,,UASB,,UASB,UASB。96 26[23](UASB)。UASB,COD10000mg/L,COD9～11kg/(m3·d),24h,COD85%,COD1500mg/L。,。[24],UASB,pH4.5、COD16g/L,COD90%。7,pH。,UASB。pH,。2.3 UASB+MBR[25]800m3/d,UASB—MBR—DTRO,—,,。《》(GB/T18920—2002)。[26](UASB)(MBR)。COD1491～2965mg/L,COD、BOD、NH3-N73%、98.3%61.7%。UASB/MBR,。,UASB(HRT)13h、MBRHRT7.5h,COD,COD1000～9000mg/L,COD199mg/L,COD80%[27]。BOD/COD,。UASB—MBR,。COD:2000～2300mg/L、BOD:1000～1200mg/L、NH3-N:35～65mg/L、TN:30～70mg/L、pH:5.5～6。COD:40～45mg/L,BOD:15～20mg/L,SS:1～5mg/L,《》(GB8978—1996)[28]。3 、、、,。80,,UASB、、、、。UASB,UASB。:[1] VanderMeer.Mathemticaldescriptionofanaerobictreat-mentofwasterinuplloweractors[J].BiotechBioeng,1983,25(11):2531-2556.[2] VieiraSM.ApplicationoftheUASBtechnologyforsew-agetreatmentinasmallcommunitySumare,SaoPauloStaste[J].WatSeiTech,1994,30(12):203-210.[3] DriessenWJBM,TielbandMH,WereijkenTLFMEx-perienceonanacerbictreatmentofdistilleryeffluentwiththeUASBprocess[J].WatSciTech,1994,30(12):193.[4] ,.UASB[J].,2004,23(2):44-47.[5] ,,.UASB[J].,2009(1):28-29.[6] ,,.UASB—SBR[J].,2005,25(10):21-23.[7] ,,.UASB[J].,2002,28(3):15-18.[8] ,.UASB[J].(),2002,30(3):66-71.[9] ,,,.UASB[J].,2007,23(11):67-68,73.[10] ,,.UASB[J].(),2008,40(8):393-396.[11] .UASB[J].,2008,35(8):88-90.[12] ,,,.UASB[J].,2002,22(1):28-30.[13] .UASB[J].,2009,22(1):30-33.[14] ,,,.UASB+SBR[J].,2005,5(5):78-81.(下转第160页)9713 :UASB,,BAV;BAV(),0.8cm2()50mmHg;EF0.55,75mm,55mm,[11],,、、,CDFI,,。,,。:[1] ,.[M].(3).,1994:422.[2] JoaquinG,LailaWC,PaulCS,etal.BicuspidAorticValveEndocarditisDuetoCardiobacteriumvalvarum:CaseReportandReviewofLiterature[J].InfectDisClinPract,2007,15(6):364-367.[3] .[J].,2002,18(10):761.[4] .[M].:,2001:108-109.[5] SabistonDC,SpencerFC.Surgeryofthechest,6thed[J].Philadelphia:W.B.SaunderCompany,1995:1733-1741.[6] FedakPWM,VermaS,DavidTE,etal.Clinicalandpathophysiologicalimplicationsofabicuspidaorticvalve.Circulation,2002(106):900-904.[7] SchmidFX,BielenbergK,SchneiderA,etal.Ascendingaorticaneurysmassociatedwithbicuspidandtricuspidaorticvalve:involvementandclinicalrelevanceofsmoothmusclecellapoptosisandexpressionofcelldeath-initia-tingproteins[J].EurJCardiothoracSurg,2003(23):537-543.[8] BauerM,PasicM,MeyerR,etal.Morphometricanalysisofaorticmediainpatientswithbicuspidandtricuspidaor-ticvalve[J].AnnThoracSurg,2002(74):58-62.[9] FerencikM,PapeLA.Changesinsizeofascendingaortaandaorticvalefunctionwithtimeinpatientswithcongen-itallybicuspidaorticvales[J].AnnJCardiol,2003,92(1):43-49.[10] NkomoVT,EnriquezSaranoM,AmmashNM,etal.Bi-cuspidaorticvalveassociatedwithaorticdilatation:acommunity-basedstudy[J].ArteriosclerThrombVascBiol,2003(23):351-356.[11] BonowT.ACC/AHAtaskforcereport[J].JACC,1998,32(5):150-151.(上接第97页)[15] ,,.UASB、SBR[J].,2008,37(3):263-266.[16] ,,.UASB/SBR[J].,2009,25(8):49-51.[17] ,,.UASB-SBR[J].,2002,25(2):104-108.[18] ,,.UASB-SBR[J].,2003,19(6):70-71.[19] .UASB+CASS[J].,2008(2):90,92.[20] ,,,.UASB-CASS[J].,2007,33(2):53-55.[21] ,.UASB-CASS—[J].,2006,32(5):23-24.[22] ,,.UASB[J].,2008,16(3):48-50.[23] ,,,.UASB[J].,2008,36(2):38-40.[24] ,,,.UASB[J].,2007,27(12):28-30.[25] ,,,.UASB-MBR-DTRO[J].,2009,33(10):49-52.[26] ,,,.UASB+MBR[J].,2003,16(6):215-217.[27] ,,.UASB/MBR[J].,2009,25(15):52-54.[28] ,,.UASB-MBR[J].,2009,35(5):64-66.160 26